Carna

Website

Carna Inc.

13 Investors
Biotechnology
BOSTON, MA

Carna Biosciences, Inc. is a biotechnology company dedicated to drug discovery and the development of small molecule drugs. The company aims to address unmet medical needs by offering innovative therapeutic solutions in areas where current treatments are either inadequate or non-existent.

Products & Team

Drug Discovery Business

Pharmaceutical DevelopmentSeed

Carna Biosciences spearheads a robust drug discovery business, primarily focusing on the development of small molecule drugs. Their research is driven by a commitment to innovation, with an emphasis on creating novel therapeutic solutions for challenging medical conditions.

Value Proposition

The product aims to fill gaps in the medical field by providing new treatment options for conditions that lack effective therapies.

Pain Points

Addressing unmet medical needs and providing new therapies where standard care is insufficient

Small molecule drug developmentInnovative research strategiesFocus on unmet medical needs

Salvatore Viscomi

Company Signatory
Chief Executive Officerat Carna Inc.
Joined Carna Inc.
February 2025
Industry
Biotechnology
Primary business sector
Founded
2025
Year established
Location
BOSTON, MA
Primary headquarters

Funding History

Total Raised:
$3.4M
E

Equity Offering

January 2025
$10.0M
Target
Use of Proceeds
Issuer has a small employee population comprised primarily of individuals who are also executive officers, some of whom are also directors and promoters; consequently, a high percentage of gross proceeds compensate, repay or reimburse such individuals.
Progress
34%
Raised
$3.4M
Target
$10.0M
#000205500625000001